Efficacy and safety of immune checkpoint inhibitors combined anti-angiogenic therapy in patients with unresectable hepatocellular carcinoma: A meta-analysis

This study aimed to compare the efficacy and safety of immune checkpoint inhibitors (ICIs) combined with antiangiogenic agents in patients with unresectable hepatocellular carcinoma (HCC). METHODS: We conducted a systematic literature search of articles published between the establishment of the dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Xian, Feng, Wu, Cailiang, Zhang, Guojun, Xu, Guohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646576/
https://www.ncbi.nlm.nih.gov/pubmed/36343054
http://dx.doi.org/10.1097/MD.0000000000031479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646576/
https://www.ncbi.nlm.nih.gov/pubmed/36343054
http://dx.doi.org/10.1097/MD.0000000000031479

Ejemplares similares